GLP-2TZ / BPC-157 – 30mg / 1.3mg
The GLP-2TZ / BPC-157 Blend combines GLP-2TZ, a dual GLP-1 and GIP receptor agonist, with BPC-157, a peptide being studied for its potential to support tissue regeneration and cellular repair. This blend is of particular interest for research involving metabolic regulation, glucose control, weight management, and tissue health.
$200.00
A GLP-2TZ and BPC-157 blend combines the metabolic benefits of a dual GLP-1 and GIP receptor agonist with the regenerative effects of BPC-157. GLP-2TZ improves glycemic control and weight management, while BPC-157 supports tissue repair and reduces inflammation. Together, they provide a synergistic approach for both metabolic health and recovery.
Research shows that GLP-2TZ enhances insulin secretion and decreases glucagon release, promoting better glucose regulation. Additionally, it reduces appetite and increases energy expenditure, contributing to significant weight loss. Meanwhile, BPC-157 accelerates healing by promoting angiogenesis, reducing inflammation, and protecting the gut lining, making it useful for tissue regeneration.
Moreover, GLP-2TZ’s dual-action on glucose and appetite control, combined with BPC-157’s tissue repair properties, offers a comprehensive solution for weight management and recovery. This blend is particularly beneficial for those seeking metabolic support while also focusing on injury recovery or gastrointestinal health.
As research progresses, the potential applications of this peptide blend continue to expand. Early studies suggest it may offer benefits beyond glycemic control, including enhanced tissue regeneration and support for inflammatory conditions.
